Allogeneic, or off-the-shelf, chimeric antigen receptor (CAR) T-cell therapies will bring new logistical challenges, said Aklilu Tedla, vice president, insights and engagement, regulatory science, cell and gene, Cardinal Health.
Allogeneic, or off-the-shelf, chimeric antigen receptor (CAR) T-cell therapies will bring new logistical challenges, said Aklilu Tedla, vice president, insights and engagement, regulatory science, cell and gene, Cardinal Health.
Transcript
How might the advent of allogeneic CAR T-cell therapies create new logistic problems for storing the treatments and being prepared for potential adverse events?
Logistics, I think you're going to need greater visibility into the supply chain. Right? And you're going to have to think about cold storage and visibility throughout the entire logistical journey. Okay? So, I think that's going to be new, and actually worth thinking about that long and hard about what role we can play there to make sure that the logistical aspects are being met.
This is one of the things that are actually high risk for manufacturers of these therapies, right, is they're innovating to bring them to the market, but then, how can they make sure that as they send them to the patient, that there's visibility into the supply chain, so you can make sure not just about the outcome, but the safety of the products.
You can think of adverse events in terms of at the time of administration, which I think where they're administered today, in hospitals, or in certain settings, you can have the type of monitoring that’s there. What I think is important is how do you monitor continuously? That raises questions about how do you monitor in the home, and in other areas that the patients are, and over what time? So, I think that is something that we're, for example, actively trying to solve.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More